Email updates

Keep up to date with the latest news and content from Infectious Agents and Cancer and BioMed Central.

Open Access Highly Accessed Review

Using antimicrobial adjuvant therapy in cancer treatment: a review

Kenneth Alibek12, Aliya Bekmurzayeva3, Assel Mussabekova3* and Bolat Sultankulov3

Author Affiliations

1 Nazarbayev University, 53 Kabanbay Batyr Avenue, Astana 010000, Kazakhstan

2 Republican Scientific Center for Emergency Care, 3 Kerey and Zhanibek Khanov Street, Astana 010000, Kazakhstan

3 “Nazarbayev University Research and Innovation System” private institution, Nazarbayev University, 53 Kabanbay Batyr Avenue, Astana 010000, Kazakhstan

For all author emails, please log on.

Infectious Agents and Cancer 2012, 7:33  doi:10.1186/1750-9378-7-33

Published: 20 November 2012

Abstract

Recent clinical and pre-clinical data demonstrate that adjuvant antimicrobial therapy is beneficial in cancer treatment. There could be several reasons for this effect, which include treating cancer associated bacteria and viruses, prophylaxis of post-chemotherapy infections due to immunosuppression, and antiproliferative effect of certain antimicrobials. Targeting cancer associated viruses and bacteria with antimicrobial agents is currently used for gastric, cervical, hematopoietic, liver and brain cancer. However this treatment is effective only in combination with conventional therapies. Antimicrobials can also have a direct antiproliferative and cytotoxic effect, and can cause apoptosis. Moreover, some antimicrobials are known to be helpful in overcoming side effects of drugs commonly used in cancer treatment. Chemotherapy related bacteremia and neutropenia can be overcome by the appropriately timed use of antimicrobials. This review summarizes the data on the effects of antivirals and antibiotics on cancer treatment and describes their mechanisms.

Keywords:
Cancer; Antibiotic; Antiviral; Chemotherapy; Bacteria; Virus; Apoptosis; Neutropenia